PRM11 - Weakness of Registration Bioequivalent Drugs
| Autor: | Krakowian, P, Iwanczuk, T, Zaremba, A, Misiak, J, Tatara, T, Wysoczanski, W |
|---|---|
| Zdroj: | In Value in Health November 2016 19(7):A359-A359 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|
| Autor: | Krakowian, P, Iwanczuk, T, Zaremba, A, Misiak, J, Tatara, T, Wysoczanski, W |
|---|---|
| Zdroj: | In Value in Health November 2016 19(7):A359-A359 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|
Full Text from ScienceDirect